Symbicort ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
228	Bronchiolitis obliterans	2

228. Bronchiolitis obliterans

---

Clinical trials : 97 /  Drugs : 118 - (DrugBank : 32) / Drug target genes : 33 - Drug target pathways : 156

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01432080 (ClinicalTrials.gov)	September 2011	8/9/2011	Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant	Does Increasing Immunosuppression Prevent Transplant-associated Lung-disease Triggered by Viral Respiratory Tract Infection Following Allogeneic Stem Cell Transplant? A Pilot Study	Respiratory Tract Infections;Bronchiolitis Obliterans;Cryptogenic Organizing Pneumonia;Lung Diseases, Interstitial	Drug: Prednisone;Drug: Azithromycin;Drug: Montelukast;Drug: Symbicort	Maisonneuve-Rosemont Hospital	The Canadian Blood and Marrow Transplant Group	Terminated	18 Years	N/A	All	12	Phase 2	Canada
2	NCT00624754 (ClinicalTrials.gov)	March 2008	15/2/2008	Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT	recipientsProspective Evaluation of the Efficacy of Budesonide/Formoterol (Symbicort®) in Bronchiolitis Obliterans in Allogeneic Haematopoietic Stem Cell Transplantation (AHSCT) Recipients	Obstructive Airway Disease	Drug: Formoterol/Budesonide;Drug: lactose	Assistance Publique - Hôpitaux de Paris	AstraZeneca	Completed	16 Years	N/A	Both	32	Phase 2	France